CROI 2019 Program and Conference Information

Poster Sessions

680 LOWER CARDIOVASCULAR DISEASE RISK ASSOCIATEDWITH INTEGRASE INHIBITORS Jane A. O’Halloran, John Sahrmann, Anne M. Butler, Margaret A. Olsen, William Powderly Poster P-O1 CRYPTOCOCCAL MENINGITIS SCREENING, PREEMPTIVE THERAPY, AND OUTCOMES Poster Hall - 4EF 2:30 PM - 4:00 PM 705 SCREENING AND PREEMPTIVE ANTIFUNGAL THERAPY FOR SUBCLINICAL CRYPTOCOCCAL DISEASE Admire Hlupeni, Rhoderick Machekano, Kathryn F. Boyd, Takudzwa Chagumaira, Primrose Nyamayaro, Chiratidzo E. Ndhlovu, Azure T. Makadzange SCREENING FOR TALAROMYCES AND CRYPTOCOCCAL ANTIGENEMIA IN AIDS PATIENTS IN GUANGDONG Linghua Li, Liya Li, Yaozu He, Haodi Wang, Kaiyin He, Xiaoping Tang, Thuy Le, Weiping Cai THE COST-EFFECTIVENESS OF AMBISOME FOR ASYMPTOMATIC CRYPTOCOCCAL INFECTION Radha Rajasingham, David Meya, Elizabeth Nalintya, Bruce Larson, David R. Boulware CRYPTOCOCCAL ANTIGENEMIA INHIV PATIENTSWITH VIROLOGIC FAILURE IN UGANDA Edward Mpoza, David Meya, Maria S. Nabaggala, Lillian Tugume, Kenneth Ssebambulidde, Joshua Rhein, David R. Boulware, Radha Rajasingham CYTOMEGALOVIRUS VIREMIA ASSOCIATEDWITHMORTALITY IN CRYPTOCOCCAL MENINGITIS Caleb P. Skipper, Mark R. Schleiss, Jason C. Zabeli, Nelmary Hernandez- Alvarado, Sarah Lofgren, Henry Nabeta, Kabanda Taseera, Abdu Musubire, Charlotte Schutz, Ananta Bangdiwala, Katherine Huppler Hullsiek, Conrad Muzoora, David Meya, Graeme Meintjes, David R. Boulware, for the COAT Trial Team 706 707 708 709

Poster Sessions • Wednesday

Poster P-O2WHAT’S APPWITH OTHER OIs? Poster Hall - 4EF

2:30 PM - 4:00 PM

710

ASYMPTOMATIC TALAROMYCESMARNEFFEI ANTIGENEMIA AND MORTALITY IN ADVANCED HIV DISEASE Nguyen T. Thu, Vu Quoc Dat, Jasper F. Chan, Hien T. Ha, Dung T. Nguyen, Anh T. Ho, Patrick C. Woo, Kwok-Yung Yuen, Sheryl Lyss, Moses Bateganya, Kinh V. Nguyen, Thuy Le

711

PREDICTIVEMODELING OFMORTALITY IN INVASIVE TALAROMYCOSIS INHIV PATIENTS Shengxin Tu, Cliburn Chan, Thuy Le

712

WITHHOLDING PCP PROPHYLAXIS INVIRALLY SUPPRESSED HIV PATIENTS FROMCOHERE Andrew Atkinson, for the Opportunistic Infections Project Team of COHERE

CROI 2019 113